glp-1 for dementia Popular obesity drug fails in hotly anticipated Alzheimer's trials | Science Can blockbuster GLP-1 weight loss

It combines GLP-1 with gastric inhibitory polypetide (GIP) RAs, activating two metabolic pathways

Obviously we don't have the data yet, but I am willing to take the gamble for myself and loved ones

semaglutide's gastric-slowing action could theoretically reduce this by allowing more time for bile reabsorption, or it could trigger nausea in an already-irritated gut

Where estrogen helps maintain the existing architecture of synaptic networks, GLP-1 signaling supports the biological machinery that allows those networks to adapt, strengthen, and repair

Nausea, GI discomfort, constipation, fatigue, and other symptoms can occur, especially when starting treatment or adjusting the dose